Human Genome Epidemiology Literature Finder
|
Records 1 - 16 (of 16 Records) |
| Query Trace: Neoplasms and BW4[original query] |
|---|
| Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors. Human immunology 2010 Oct 71 (10): 976-81. Al Omar Suliman, Middleton Derek, Marshall Ernie, Porter Dawn, Xinarianos George, Raji Olaide, Field John K, Christmas Stephen |
| KIR/HLA combination associated with the risk of complications in celiac disease. The International journal of biological markers 0 26 (4): 221-8. Caggiari Laura, Toffoli Giuseppe, De Re Valli, Orzes Nicoletta, Spina Michele, De Zorzi Mariangela, Maiero Stefania, Cannizzaro Renato, Canzonieri Vincen |
| Activating killer-cell immunoglobulin-like receptors (KIR) and their cognate HLA ligands are significantly increased in autism. Brain, behavior, and immunity 2012 Oct 26 (7): 1122-7. Torres Anthony R, Westover Jonna B, Gibbons Cole, Johnson Randall C, Ward David |
| Analysis of KIR gene frequencies and HLA class I genotypes in prostate cancer and control group. International journal of immunogenetics 2012 Oct 39 (5): 423-8. Portela P, Jobim L F, Salim P H, Koff W J, Wilson T J, Jobim M R, Schwartsmann G, Roesler R, Jobim |
| Analysis of KIR gene frequencies and HLA class I genotypes in breast cancer and control group. Human immunology 2013 Sep 74 (9): 1130-3. Jobim Maria Regina, Jobim Mariana, Salim Patrícia H, Portela Pâmela, Jobim Luiz Fernando, Leistner-Segal Sandra, Bittelbrunn Ana Cristina, Menke Carlos Henrique, Biazús Jorge Villanova, Roesler Rafael, Schwartsmann Gilber |
| Quantitative effect of natural killer-cell licensing on hepatocellular carcinoma recurrence after curative hepatectomy. Cancer immunology research 2014 Dec 2 (12): 1142-7. Tanimine Naoki, Tanaka Yuka, Kobayashi Tsuyoshi, Tashiro Hirotaka, Miki Daiki, Imamura Michio, Aikata Hiroshi, Tanaka Junko, Chayama Kazuaki, Ohdan Hide |
| Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy. PloS one 2014 9 (1): e84940. De Re Valli, Caggiari Laura, De Zorzi Mariangela, Talamini Renato, Racanelli Vito, D' Andrea Mario, Buonadonna Angela, Zagonel Vittorina, Cecchin Erika, Innocenti Federico, Toffoli Giusep |
| Killer Immunoglobulin-Like Receptor Profiles Are not Associated with Risk of Amoxicillin-Clavulanate-Induced Liver Injury in Spanish Patients. Frontiers in pharmacology 2016 7 280. Stephens Camilla, Moreno-Casares Antonia, López-Nevot Miguel-Ángel, García-Cortés Miren, Medina-Cáliz Inmaculada, Hallal Hacibe, Soriano German, Roman Eva, Ruiz-Cabello Francisco, Romero-Gomez Manuel, Lucena M Isabel, Andrade Raúl |
| Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells. Cancer research 2016 Jan . Vineretsky Karin A, Karagas Margaret R, Christensen Brock C, Kuriger-Laber Jacquelyn K, Perry Ann E, Storm Craig A, Nelson Heather |
| Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 10 24 (1): 189-196. Erbe Amy K, Wang Wei, Carmichael Lakeesha, Kim KyungMann, Mendonça Eneida A, Song Yiqiang, Hess Dustin, Reville Patrick K, London Wendy B, Naranjo Arlene, Hank Jacquelyn A, Diccianni Mitchell B, Reisfeld Ralph A, Gillies Stephen D, Matthay Katherine K, Cohn Susan L, Hogarty Michael D, Maris John M, Park Julie R, Ozkaynak M Fevzi, Gilman Andrew L, Yu Alice L, Sondel Paul |
| The association of HLA/KIR genes with non-small cell lung cancer (adenocarcinoma) in a Han Chinese population. Journal of Cancer 2019 10 10 (20): 4731-4738. Li Yingfu, Liu Shuyuan, Hong Chao, Ma Qianli, Tan Fang, Liu Chengxiu, Ku?nierczyk Piotr, Li Chuanyin, Shi Li, Yao Yufe |
| [A protective effect conferred by KIR3DL1 and its cognate ligand against cervical cancer among ethnic Han Chinese population and its potential mechanism]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 10 36 (10): 1035-1038. Zhen Jianxin, Zhu Leilei, Li Weihong, Hu Haiyan, Deng Zhihui, Xiong Liku |
| Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk. Scientific reports 2021 Apr 11 (1): 7932. Ashouri Elham, Rajalingam Karan, Barani Shaghik, Farjadian Shirin, Ghaderi Abbas, Rajalingam Ra |
| Polymorphisms of Killer Ig-like Receptors and the Risk of Glioblastoma. Journal of clinical medicine 2023 7 12 (14): . Haeyoun Choi, In-Cheol Baek, Soon A Park, Jae-Sung Park, Sin-Soo Jeun, Tai-Gyu Kim, Stephen A |
| Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial. Cancer immunology, immunotherapy : CII 2023 2 . Feils A S, Erbe A K, Birstler J, Kim K, Hoch U, Currie S L, Nguyen T, Yu D, Siefker-Radtke A O, Tannir N, Tolaney S M, Diab A, Sondel P |
| The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer. Immunobiology 2023 1 228 (2): 152319. Roshan Zamir Mina, Ariafar Ali, Ghaderi Abbas, Amirzargar Aliakb |
- Page last reviewed:Feb 1, 2024
- Content source: